Dealing with childhood pneumonia in developing countries: how can we make a difference?

scientific article published on April 2007

Dealing with childhood pneumonia in developing countries: how can we make a difference? is …
instance of (P31):
scholarly articleQ13442814
editorialQ871232
review articleQ7318358

External links are
P356DOI10.1136/ADC.2006.111849
P932PMC publication ID2083673
P698PubMed publication ID17376934
P5875ResearchGate publication ID6430229

P50authorZulfiqar BhuttaQ59179623
P2860cites workImpact of improved stoves, house construction and child location on levels of indoor air pollution exposure in young Guatemalan childrenQ28259362
Potential interventions for the prevention of childhood pneumonia in developing countries: improving nutritionQ33729628
Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trialQ33986009
WHO estimates of the causes of death in childrenQ33986016
Effect of handwashing on child health: a randomised controlled trialQ34434418
Chest radiography in children aged 2-59 months diagnosed with non-severe pneumonia as defined by World Health Organization: descriptive multicentre study in PakistanQ35040622
Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction into routine childhood immunization in KenyaQ35070815
Clinical efficacy of co-trimoxazole versus amoxicillin twice daily for treatment of pneumonia: a randomised controlled clinical trial in PakistanQ35567226
Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2-59 months: a multi-centre, double blind, randomised controlled trial in PakistanQ36155303
Randomized trial of sulfamethoxazole + trimethoprim versus procaine penicillin for the outpatient treatment of childhood pneumonia in ZimbabweQ36668808
Global estimate of the incidence of clinical pneumonia among children under five years of age.Q37055648
Randomized controlled trial of standard versus double dose cotrimoxazole for childhood pneumonia in PakistanQ37056232
Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trialQ37324425
Potential interventions for the prevention of childhood pneumonia in developing countries: a systematic review.Q39138997
Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxycillin for pneumonia among children in Pakistan: randomised controlled trial. Pakistan Co-trimoxazole Study GroupQ39472560
High ampicillin resistance in different biotypes and serotypes of Haemophilus influenzae colonizing the nasopharynx of healthy school-going Indian childrenQ39743298
Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trialQ44146950
Percentage, bacterial etiology and antibiotic susceptibility of acute respiratory infection and pneumonia among children in rural Senegal.Q44358190
Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective studyQ44751079
A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infectionQ46198228
Pneumonia: the leading killer of children.Q64883116
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectpneumoniaQ12192
P304page(s)286-288
P577publication date2007-04-01
P1433published inArchives of Disease in ChildhoodQ4787296
P1476titleDealing with childhood pneumonia in developing countries: how can we make a difference?
P478volume92